Group One Trading, L.P. Vertex Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

  • $2.54 Billion
  • Q4 2024

A detailed history of Group One Trading, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 30,402 shares of VRTX stock, worth $14.4 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
30,402
Previous 24,323 24.99%
Holding current value
$14.4 Million
Previous $11.3 Million 8.22%
% of portfolio
0.48%
Previous 0.47%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$396.64 - $516.74 $2.41 Million - $3.14 Million
6,079 Added 24.99%
30,402 $12.2 Million
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $6.85 Million - $7.53 Million
14,886 Added 157.74%
24,323 $11.3 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $2.24 Million - $2.77 Million
-5,696 Reduced 37.64%
9,437 $4.42 Million
Q1 2024

May 10, 2024
BUY
$407.69 - $446.08 $6.17 Million - $6.75 Million
15,133 New
15,133 $6.33 Million
Q4 2022

Feb 09, 2023
BUY
$285.76 - $321.48 $5.78 Million - $6.5 Million
20,221 Added 81.27%
45,103 $13 Million
Q3 2022

Nov 09, 2022
BUY
$273.83 - $305.53 $1.16 Million - $1.29 Million
4,222 Added 20.44%
24,882 $7.2 Million
Q2 2022

Aug 11, 2022
BUY
$234.96 - $292.55 $1.26 Million - $1.56 Million
5,344 Added 34.89%
20,660 $5.82 Million
Q1 2022

May 12, 2022
SELL
$221.42 - $260.97 $18.4 Million - $21.7 Million
-83,121 Reduced 84.44%
15,316 $4 Million
Q4 2021

Feb 11, 2022
BUY
$177.01 - $223.45 $4.69 Million - $5.92 Million
26,514 Added 36.86%
98,437 $21.6 Million
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $972,613 - $1.09 Million
5,362 Added 8.06%
71,923 $13 Million
Q2 2021

Aug 10, 2021
SELL
$187.49 - $221.1 $3.06 Million - $3.61 Million
-16,319 Reduced 19.69%
66,561 $13.4 Million
Q1 2021

May 12, 2021
SELL
$207.02 - $241.31 $3.39 Million - $3.95 Million
-16,367 Reduced 16.49%
82,880 $17.8 Million
Q4 2020

Feb 10, 2021
BUY
$207.01 - $276.09 $20.5 Million - $27.4 Million
99,247 New
99,247 $23.5 Million
Q2 2020

Aug 13, 2020
SELL
$225.48 - $295.8 $2.63 Million - $3.45 Million
-11,669 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$199.77 - $247.81 $2.33 Million - $2.89 Million
11,669 New
11,669 $2.78 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $951,988 - $1.11 Million
-6,533 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$151.6 - $177.13 $2.55 Million - $2.98 Million
-16,837 Reduced 72.05%
6,533 $1.07 Million
Q4 2017

Feb 09, 2018
BUY
$137.28 - $155.55 $3.21 Million - $3.64 Million
23,370 New
23,370 $3.5 Million
Q3 2017

Nov 15, 2017
SELL
$148.13 - $162.24 $2.6 Million - $2.85 Million
-17,571 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
17,571
17,571 $2.26 Million

Others Institutions Holding VRTX

# of Institutions
1,753
Shares Held
227M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email